ArticleOxidative medicine and cellular longevity2017

NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib.

Ibrahim H Kankia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.